GB Patent

GB0525898D0 — Screening compounds for activity in modulating chloride ion transport

Assigned to PHARMO BIOSCIENCE AS · Expires 2006-02-01 · 20y expired

What this patent protects

A method for screening a test compound for activity in modulating the activity of the chloride channel ClC-7 either directly or by modulating the subcellular localization of Ostm1 comprises determining whether test compound inhibits the binding of Ostm1 to ClC-7. Compounds active…

USPTO Abstract

A method for screening a test compound for activity in modulating the activity of the chloride channel ClC-7 either directly or by modulating the subcellular localization of Ostm1 comprises determining whether test compound inhibits the binding of Ostm1 to ClC-7. Compounds active in the screen are candidates for use in treating bone resorption conditions such as Osteoporosis by modulating the activity of osteoclasts.

Drugs covered by this patent

Patent Metadata

Patent number
GB0525898D0
Jurisdiction
GB
Classification
—
Expires
2006-02-01
Drug substance claim
No
Drug product claim
No
Assignee
PHARMO BIOSCIENCE AS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.